Jonathan Amspacher, MD
Plastic and Reconstructive Surgery · Saint Joseph, MONPI 1154527190
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for plastic and reconstructive surgery clinicians in MO, where the typical reported total is $3,093.
Across 52 payments — averaging $27.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mentor Worldwide LLC$253
- Axogen$184
- Endo Pharmaceuticals Inc.$158
- Avita Medical Americas, LLC$153
- RTI Surgical, Inc$130
- AbbVie$124
- plus $443 from 13 others
What the payments were for
- Food & beverage$1,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mentor Worldwide LLC | 6 | $253 |
| Axogen | 2 | $184 |
| Endo Pharmaceuticals Inc. | 10 | $158 |
| Avita Medical Americas, LLC | 2 | $153 |
| RTI Surgical, Inc | 1 | $130 |
| AbbVie(2 entities) | 7 | $124 |
| Johnson & Johnson | 4 | $81 |
| Lilly USA, LLC | 4 | $61 |
| LEO Pharma Inc. | 2 | $38 |
| Endo USA, Inc. | 2 | $37 |
| Amgen | 2 | $34 |
| Polynovo North America LLC | 1 | $29 |
| KCI USA, Inc. | 2 | $29 |
| Kerecis Limited | 1 | $26 |
| Sientra, Inc. | 2 | $26 |
| Baxter Healthcare | 1 | $24 |
| Acera Surgical, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,444 in reported general payments places this provider in the 35th percentile of 61 plastic and reconstructive surgery providers in Missouri.
See all plastic and reconstructive surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 149 | $728 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $500 |
| Oxycodone Hcl | 26 | $138 |
| Hydroxyzine Pamoate | 22 | $102 |
| Tramadol Hcl | 50 | $72 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Saint Joseph
- Thomas McEwanSaint Joseph$330
- Terence MyckatynSaint Louis$399K
- David CaplinSaint Louis$81K
- Patricia McGuireSaint Louis$66K
- Bruce KraemerSt Louis$53K
- Mitchell PetSaint Louis$42K
- Kamlesh PatelSaint Louis$41K
- John HoldsSaint Louis$40K
- Marissa Morningstar TenenbaumSaint Louis$28K
- Charles NathanSaint Louis$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.